Corcept officer Lyon proposes $176K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Corcept Therapeutics Inc. officer Joseph Douglas Lyon reported 1,540 common shares for sale, with an aggregate market value of $175,806 and an approximate sale date of August 3, 2026. The notice lists Stifel Nicolaus & Company Inc. as broker. Lyon acquired 749 shares through an option exercise on June 2, 2025, and 791 shares through an option exercise on June 3, 2025.
Key Figures
Key Terms
Aggregate Market Value financial
Option Exercise financial
Approximate Date of Sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.